Endometrial cancer secondary prevention: Difference between revisions
No edit summary |
YazanDaaboul (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Endometrial cancer}}{{CMG}}{{AE}}{{MD}} | {{Endometrial cancer}} | ||
{{CMG}}{{AE}}{{MD}} | |||
==Overview== | ==Overview== | ||
The risk of recurrence of endometrial cancer is highest within 2 years. Life-time follow-up is needed, especially within the first 2 years following diagnosis and successful treatment. Routine follow-up visists occur at 3-4 months interval during the first 2 years, at 6 months interval during the next 3 years, and yearly thereaafter. | |||
==Secondary Prevention== | |||
The risk of recurrence of endometrial cancer is highest within 2 years. Life-time follow-up is needed, especially within the first 2 years following diagnosis and successful treatment.<ref> Follow-up after treatment for uterine cancer. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/uterine/treatment/follow-up/?region=ns. URL Accessed on September, 22 2015</ref> | |||
1. Follow-up visits are routinely scheduled as shown below: | |||
:* Every 3–4 months during the first 2 years | |||
:* Every 6 months during the next 3 years | |||
:* Yearly thereafter | |||
2. Follow-up visit includes: | |||
:* Complete [[physical examination]] | |||
:* Pelvic examination | |||
::* Inguinal nodes | |||
::* [[Pap test]] to look for cancer cells in the upper part of the vagina, near the area where the uterus used to be | |||
3. The following test are recommended to check for recurrence: | |||
:* [[Chest x-ray]] may be done yearly | |||
:* [[CT scan]] may be done if the woman has symptoms or something is found during the examination | |||
:* Serum concentration of cancer antigen 125 (CA125) may be checked for abrupt elevations | |||
4. If a recurrence is detected during follow-up, a thorough oncological reassessment is required for adequate management. | |||
==References== | ==References== | ||
Revision as of 16:13, 28 September 2015
|
Endometrial cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Endometrial cancer secondary prevention On the Web |
|
American Roentgen Ray Society Images of Endometrial cancer secondary prevention |
|
Risk calculators and risk factors for Endometrial cancer secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Monalisa Dmello, M.B,B.S., M.D. [2]
Overview
The risk of recurrence of endometrial cancer is highest within 2 years. Life-time follow-up is needed, especially within the first 2 years following diagnosis and successful treatment. Routine follow-up visists occur at 3-4 months interval during the first 2 years, at 6 months interval during the next 3 years, and yearly thereaafter.
Secondary Prevention
The risk of recurrence of endometrial cancer is highest within 2 years. Life-time follow-up is needed, especially within the first 2 years following diagnosis and successful treatment.[1]
1. Follow-up visits are routinely scheduled as shown below:
- Every 3–4 months during the first 2 years
- Every 6 months during the next 3 years
- Yearly thereafter
2. Follow-up visit includes:
- Complete physical examination
- Pelvic examination
- Inguinal nodes
- Pap test to look for cancer cells in the upper part of the vagina, near the area where the uterus used to be
3. The following test are recommended to check for recurrence:
- Chest x-ray may be done yearly
- CT scan may be done if the woman has symptoms or something is found during the examination
- Serum concentration of cancer antigen 125 (CA125) may be checked for abrupt elevations
4. If a recurrence is detected during follow-up, a thorough oncological reassessment is required for adequate management.
References
- ↑ Follow-up after treatment for uterine cancer. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/uterine/treatment/follow-up/?region=ns. URL Accessed on September, 22 2015